Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07665216

Chatbot Intervention Effects on Resting-State Brain Function in Anhedonia

The main aim of the present study is to investigate the effects of a Motivational Interviewing-based artificial intelligence chatbot on resting-state brain function in college students with elevated anhedonia and depressive symptoms. The study will use a randomized active-control intervention design with pre- and post-intervention resting-state functional magnetic resonance imaging assessments.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Age range

18 year–40 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Electronic Science and Technology of China

Chengdu, Sichuan, China

Location status: Recruiting

Location contact

Benjamin Becker, Dr

CONTACT

[email protected]

(852) 3917-5097

About this study

Anhedonia represents a core characteristic of depression and is characterized by reduced experience of pleasure. It is closely related to decreased motivation, altered reward processing, and alterations in intrinsic brain network function. Resting-state fMRI provides a way to examine intrinsic brain activity and functional connectivity without requiring participants to perform a specific task. This is important because changes associated with anhedonia may not only appear during reward-related tasks, but may also be reflected in spontaneous brain network organization.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18-40 years
  • Right-handed
  • Normal or corrected normal visual acuity
  • Participants must show elevated anhedonia and depressive symptoms at screening, defined as a total score of 22 or higher on the Snaith-Hamilton Pleasure Scale and a score of 14 or higher on the Beck Depression Inventory

Exclusion criteria

  • History of major central nervous system disorders, such as epilepsy, traumatic brain injury, stroke, or brain tumors.
  • History of severe mental illness, including schizophrenia spectrum disorders, bipolar disorder, or other psychotic disorders.
  • History of substance or alcohol use disorder or substance or alcohol misuse within the past 12 months that may affect study participation or outcome assessment.
  • Individuals currently at high risk of suicide, severe self-harm, or experiencing an acute psychiatric crisis.
  • Individuals who are currently using psychiatric medications or have undergone psychotherapy within the past 4 weeks that may significantly affect mood, motivation, or reward processing.
  • Severe vision or hearing impairments that cannot be corrected and would interfere with task performance.
  • Contraindications to MRI scanning, including metallic implants, pacemakers, severe claustrophobia, or other conditions incompatible with MRI.
  • Pregnancy or breastfeeding.

Treatment and study plan

MI Chatbot Interaction

Behavioral

The experimental chatbot is designed to use principles of Motivational Interviewing to support participants in exploring their personal values, motivation for change, and daily behavioral goals related to pleasure, engagement, and reward-seeking. During the intervention period, participants will interact with the chatbot regularly through brief text-based conversations. The chatbot will provide empathic, non-judgmental responses, encourage reflection on current difficulties, and help participants identify small, feasible actions that may increase daily engagement and positive experiences. It will not provide diagnosis, crisis counseling, or medical treatment.

Active Control Chatbot Interaction

Behavioral

Participants will interact with a chatbot matched in format and frequency of use. This chatbot will provide neutral nature-related stories or general natural history content. It will be designed to maintain participant engagement while avoiding therapeutic techniques, motivational interviewing strategies, behavioral activation guidance, or personalized mental health advice. This active control condition will help control for nonspecific effects of chatbot interaction, attention, expectancy, and digital engagement.

Primary outcomes

  1. Intervention-Related Changes in Resting-State Functional Connectivity After the Intervention

    Time frame: Baseline before the first chatbot interaction and Week 1 after completion of the chatbot intervention.

    Resting-state fMRI will be used to examine functional connectivity among predefined regions involved in reward, social, and self-referential processing. Connectivity will be estimated from Pearson correlations between regional BOLD time series and then converted using the Fisher z transformation. Changes from baseline to post-intervention will be reported as dimensionless Fisher z values.

Secondary outcomes

  1. Intervention-Related Changes in Spontaneous Activity After the Intervention

    Time frame: Baseline before the first chatbot interaction and Week 1 after completion of the chatbot intervention.

    Indices of spontaneous neural activity in regions involved in motivation, social and self-referential processing, will be extracted from resting-state fMRI scans collected at the two assessment points. These indices will include amplitude of low-frequency fluctuations or fractional amplitude of low-frequency fluctuations, as well as regional homogeneity. Baseline and post-intervention values will then be compared to characterize pre-to-post changes.

Study contacts

Contact information is provided by the study sponsor or research team.

Benjamin Becker

CONTACT

[email protected]

(852) 3917-5097

Sponsors and collaborators

Lead sponsor

University of Electronic Science and Technology of China

Other

Registry information

Official study title

Effects of a Chatbot-Based Intervention on Resting-State Functional Connectivity and Spontaneous Neural Activity in Individuals With Anhedonia

Important dates

Study start
2026
Primary completion
2028
Study completion
2028
First posted
Jun 24, 2026
Registry last updated
Jul 9, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.